SBL
TMDX icon

Sargent Bickham Lagudis’s Transmedics TMDX Stock Holding History

Sargent Bickham Lagudis’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,403
Closed -$138K – 1118
2022
Q2 		$138K Hold
4,403
– – 0.01% 283
2022
Q1 		$119K Hold
4,403
– – 0.01% 311
2021
Q4 		$84K Hold
4,403
– – 0.01% 363
2021
Q3 		$146K Hold
4,403
– – 0.01% 284
2021
Q2 		$146K Hold
4,403
– – 0.01% 297
2021
Q1 		$183K Buy
+4,403
New +$136K 0.02% 251

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Sargent Bickham Lagudis's TMDX Position: Q3 2022 in Review

Sargent Bickham Lagudis sold out of Transmedics (TMDX) in Q3 2022, closing a stake of 4,403 shares — an estimated $138K sold.

Sargent Bickham Lagudis first reported a position in TMDX in Q1 2021 and held it in 6 quarters. The position peaked at $183K in Q1 2021. 178 funds tracked by Wall St. Rank hold TMDX as of Q3 2022.

  • Sargent Bickham Lagudis reported no remaining Transmedics position as of Q3 2022 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 4,403 Transmedics shares in Q3 2022, an estimated $138K.
  • Sargent Bickham Lagudis first reported a position in Transmedics in Q1 2021 and held it in 6 quarters.
  • Sargent Bickham Lagudis's Transmedics position peaked at $183K in Q1 2021.
  • 178 funds tracked by Wall St. Rank held Transmedics as of Q3 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2022, filed 27 Oct 2022.